Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Maurizio Zangari

Concepts (493)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
140
2024
3035
10.270
 Why?
Thalidomide
33
2016
397
3.190
 Why?
Boronic Acids
17
2013
197
3.040
 Why?
Pyrazines
17
2013
203
3.040
 Why?
Bone Marrow
17
2022
411
2.010
 Why?
Hematopoietic Stem Cell Transplantation
19
2024
573
1.820
 Why?
Venous Thrombosis
8
2009
102
1.810
 Why?
Antineoplastic Combined Chemotherapy Protocols
30
2024
1056
1.740
 Why?
Paraproteinemias
7
2022
80
1.720
 Why?
Angiogenesis Inhibitors
12
2009
203
1.620
 Why?
Protease Inhibitors
7
2011
64
1.450
 Why?
Chromosomes, Human, Pair 1
7
2023
113
1.400
 Why?
Humans
154
2024
54246
1.360
 Why?
Proteasome Inhibitors
6
2016
110
1.360
 Why?
Alkaline Phosphatase
7
2020
99
1.240
 Why?
Neoplasm, Residual
6
2022
166
1.210
 Why?
Antineoplastic Agents
20
2024
1300
1.210
 Why?
Prognosis
37
2024
2118
1.190
 Why?
Middle Aged
60
2023
13070
1.150
 Why?
Aged
60
2021
10041
1.140
 Why?
Thrombosis
6
2013
243
1.140
 Why?
Bone Remodeling
3
2016
177
1.100
 Why?
Bone Diseases
2
2021
109
1.090
 Why?
Osteogenesis
4
2018
377
0.990
 Why?
Immunologic Factors
5
2016
130
0.950
 Why?
Gene Expression Profiling
21
2023
1138
0.910
 Why?
Male
67
2021
27312
0.890
 Why?
Peripheral Blood Stem Cell Transplantation
6
2012
57
0.890
 Why?
Female
66
2021
28418
0.880
 Why?
Anticoagulants
6
2009
270
0.880
 Why?
Antibodies, Bispecific
4
2024
43
0.870
 Why?
Transplantation, Autologous
25
2024
476
0.870
 Why?
Neoplasms, Plasma Cell
4
2024
39
0.870
 Why?
Melphalan
11
2016
180
0.860
 Why?
Activated Protein C Resistance
4
2011
10
0.850
 Why?
Venous Thromboembolism
3
2011
75
0.780
 Why?
Parathyroid Hormone
4
2018
196
0.770
 Why?
Monoclonal Gammopathy of Undetermined Significance
7
2023
108
0.770
 Why?
Durapatite
1
2020
27
0.750
 Why?
Antibodies, Monoclonal
4
2022
562
0.740
 Why?
Gene Amplification
1
2019
57
0.710
 Why?
Thromboembolism
3
2009
56
0.710
 Why?
Myeloablative Agonists
4
2012
33
0.700
 Why?
Neoplasm Proteins
7
2020
359
0.690
 Why?
Dexamethasone
13
2024
435
0.690
 Why?
Survival Rate
19
2020
951
0.680
 Why?
Disease-Free Survival
18
2019
485
0.680
 Why?
Adult
38
2022
14182
0.680
 Why?
Factor V
4
2011
11
0.650
 Why?
Oligopeptides
3
2018
95
0.650
 Why?
Bone and Bones
4
2021
516
0.650
 Why?
Spinal Fractures
1
2018
41
0.650
 Why?
Gene Expression Regulation, Neoplastic
12
2021
866
0.640
 Why?
Thymus Gland
1
2018
45
0.630
 Why?
Translocation, Genetic
8
2021
287
0.610
 Why?
Parathyroidectomy
1
2018
75
0.600
 Why?
Disease Progression
16
2023
913
0.600
 Why?
Clinical Trials as Topic
9
2022
490
0.600
 Why?
Calcification, Physiologic
1
2017
42
0.590
 Why?
Thyroidectomy
1
2018
103
0.590
 Why?
Retrospective Studies
22
2024
6432
0.590
 Why?
Aged, 80 and over
19
2021
3429
0.590
 Why?
Pelvis
1
2017
76
0.580
 Why?
Follow-Up Studies
22
2024
2387
0.570
 Why?
Treatment Outcome
30
2022
5604
0.570
 Why?
Thrombophilia
4
2009
20
0.560
 Why?
Osteoblasts
6
2020
514
0.560
 Why?
Risk Factors
22
2021
3930
0.530
 Why?
Chromosome Aberrations
9
2023
316
0.530
 Why?
Survival Analysis
13
2021
735
0.530
 Why?
Drug Resistance, Neoplasm
7
2015
309
0.530
 Why?
Stem Cell Transplantation
10
2023
196
0.520
 Why?
Plasma Cells
9
2023
238
0.520
 Why?
Chromosome Deletion
5
2023
150
0.510
 Why?
Transplantation Conditioning
7
2019
86
0.500
 Why?
Neoplasms
3
2009
1315
0.490
 Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
24
0.480
 Why?
Animals
19
2024
14385
0.470
 Why?
Neoplasm Recurrence, Local
7
2024
644
0.470
 Why?
Polycythemia Vera
1
2013
6
0.460
 Why?
Hemostasis
3
2008
56
0.450
 Why?
Neovascularization, Pathologic
4
2009
168
0.440
 Why?
Neutropenia
2
2023
120
0.420
 Why?
Combined Modality Therapy
16
2024
692
0.410
 Why?
Mutation
6
2022
1501
0.400
 Why?
Hematopoietic Stem Cells
2
2012
215
0.390
 Why?
Bone Neoplasms
2
2010
193
0.390
 Why?
Evolution, Molecular
2
2021
103
0.380
 Why?
Amyloidosis
3
2009
85
0.380
 Why?
Doxorubicin
7
2009
259
0.370
 Why?
Anti-Anxiety Agents
1
2009
30
0.350
 Why?
In Situ Hybridization, Fluorescence
7
2023
278
0.350
 Why?
Hemorrhagic Disorders
1
2009
6
0.340
 Why?
Kaplan-Meier Estimate
10
2019
514
0.340
 Why?
Cryoglobulinemia
1
2008
12
0.340
 Why?
Mice
11
2024
6413
0.330
 Why?
Biopsy, Needle
1
2009
195
0.330
 Why?
Tumor Microenvironment
4
2023
209
0.330
 Why?
Analgesics
1
2009
106
0.320
 Why?
Pain
2
2009
405
0.320
 Why?
Pulmonary Embolism
1
2009
106
0.320
 Why?
Collagen
2
2020
223
0.320
 Why?
Risk Assessment
7
2023
1361
0.310
 Why?
Hematologic Neoplasms
2
2022
99
0.310
 Why?
Farnesyltranstransferase
1
2006
5
0.300
 Why?
Vascular Endothelial Growth Factor Receptor-2
2
2004
37
0.300
 Why?
Cell Line, Tumor
4
2023
1550
0.290
 Why?
Waldenstrom Macroglobulinemia
2
2022
41
0.290
 Why?
Osteolysis
2
2022
88
0.290
 Why?
Pyrroles
2
2004
78
0.290
 Why?
Risk
4
2014
343
0.290
 Why?
B-Cell Maturation Antigen
5
2024
72
0.290
 Why?
Sirolimus
1
2006
65
0.280
 Why?
Cell Differentiation
4
2022
720
0.280
 Why?
Cell Proliferation
8
2023
1096
0.280
 Why?
Signal Transduction
6
2021
1753
0.270
 Why?
Chromosomes, Human, Pair 17
2
2017
43
0.270
 Why?
Recurrence
10
2021
690
0.260
 Why?
Logistic Models
4
2018
990
0.260
 Why?
Time Factors
10
2021
3212
0.260
 Why?
Fluorodeoxyglucose F18
4
2021
205
0.250
 Why?
Plasmacytoma
2
2020
47
0.250
 Why?
Enoxaparin
1
2004
25
0.250
 Why?
Polycomb Repressive Complex 2
2
2021
50
0.250
 Why?
Remission Induction
10
2021
221
0.250
 Why?
Pentaerythritol Tetranitrate
1
2024
6
0.250
 Why?
Indoles
2
2004
289
0.240
 Why?
Vascular Endothelial Growth Factor A
2
2004
230
0.230
 Why?
Blood Coagulation
1
2003
69
0.220
 Why?
Prospective Studies
9
2019
2604
0.220
 Why?
Positron-Emission Tomography
3
2022
322
0.220
 Why?
Hematopoietic Stem Cell Mobilization
3
2008
61
0.210
 Why?
Immunoglobulin Light Chains
2
2017
101
0.210
 Why?
Bone Resorption
2
2022
326
0.210
 Why?
Proto-Oncogene Proteins B-raf
2
2020
90
0.210
 Why?
Immunoconjugates
1
2022
38
0.210
 Why?
Drug Approval
1
2022
47
0.210
 Why?
Randomized Controlled Trials as Topic
3
2012
596
0.210
 Why?
Hemorrhage
3
2009
208
0.210
 Why?
Chromosomal Instability
2
2019
17
0.210
 Why?
Lymphoma, B-Cell
1
2022
62
0.200
 Why?
Cell Cycle
2
2021
275
0.200
 Why?
Epigenomics
1
2021
67
0.200
 Why?
Patient Participation
1
2022
69
0.200
 Why?
SOXC Transcription Factors
1
2021
14
0.200
 Why?
Arkansas
5
2021
2094
0.190
 Why?
Diffusion Magnetic Resonance Imaging
2
2019
126
0.190
 Why?
T-Lymphocytes
4
2024
373
0.190
 Why?
Odontoblasts
1
2020
5
0.190
 Why?
U937 Cells
1
2020
15
0.190
 Why?
Calcium Phosphates
1
2020
8
0.190
 Why?
HL-60 Cells
1
2020
24
0.190
 Why?
K562 Cells
1
2020
47
0.190
 Why?
NIH 3T3 Cells
1
2020
55
0.190
 Why?
Mammals
1
2020
57
0.190
 Why?
Genes, Tumor Suppressor
2
2021
85
0.190
 Why?
MCF-7 Cells
1
2020
79
0.190
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
14
0.180
 Why?
Leukemia, Plasma Cell
1
2020
34
0.180
 Why?
Protein C
2
2011
23
0.180
 Why?
Myelodysplastic Syndromes
3
2007
79
0.180
 Why?
Practice Guidelines as Topic
1
2023
492
0.180
 Why?
Busulfan
1
2019
18
0.180
 Why?
HEK293 Cells
1
2020
245
0.180
 Why?
Kidney Diseases
2
2020
293
0.180
 Why?
Hematopoiesis, Extramedullary
1
2019
10
0.180
 Why?
HeLa Cells
1
2020
291
0.180
 Why?
Etoposide
4
2009
85
0.180
 Why?
Gene Regulatory Networks
1
2020
124
0.180
 Why?
Atrial Fibrillation
1
2022
197
0.170
 Why?
Epigenesis, Genetic
2
2020
399
0.170
 Why?
Imaging, Three-Dimensional
2
2017
171
0.170
 Why?
Healthcare Disparities
1
2022
268
0.170
 Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
11
0.170
 Why?
Genome-Wide Association Study
1
2020
190
0.170
 Why?
Fractures, Compression
1
2018
19
0.170
 Why?
Spleen
1
2019
186
0.160
 Why?
Fibrinolysis
2
2009
8
0.160
 Why?
Genomic Instability
2
2016
95
0.160
 Why?
Phosphotransferases
1
2018
24
0.160
 Why?
Predictive Value of Tests
4
2009
1048
0.160
 Why?
Cisplatin
5
2009
352
0.160
 Why?
Blood Coagulation Factors
2
2009
19
0.160
 Why?
Bacteremia
1
2019
101
0.160
 Why?
Cytokines
3
2007
676
0.160
 Why?
Adipocytes
1
2018
129
0.160
 Why?
Immunotherapy, Adoptive
3
2024
134
0.160
 Why?
beta 2-Microglobulin
3
2008
35
0.150
 Why?
Gene Rearrangement
1
2018
76
0.150
 Why?
Hexokinase
1
2017
18
0.150
 Why?
Metaphase
4
2016
55
0.150
 Why?
Heparin, Low-Molecular-Weight
2
2007
21
0.150
 Why?
Cluster Analysis
4
2012
249
0.150
 Why?
Cell Line
1
2020
1153
0.150
 Why?
Ultrasonography, Doppler
2
2007
57
0.150
 Why?
Antineoplastic Agents, Alkylating
5
2008
74
0.150
 Why?
Clonal Evolution
1
2016
60
0.140
 Why?
Renal Insufficiency
4
2010
138
0.140
 Why?
Fibrinolytic Agents
2
2007
139
0.140
 Why?
Calcium
1
2018
432
0.140
 Why?
Tumor Burden
3
2020
142
0.140
 Why?
Gene Expression Regulation, Enzymologic
1
2017
206
0.130
 Why?
Chromosomes, Human, Pair 13
3
2008
41
0.130
 Why?
Genes, Neoplasm
1
2015
36
0.130
 Why?
Tumor Suppressor Protein p53
1
2017
250
0.130
 Why?
Gene Expression
1
2018
664
0.130
 Why?
Salvage Therapy
6
2006
145
0.130
 Why?
Immunotherapy
2
2016
263
0.130
 Why?
Gene Dosage
1
2015
91
0.130
 Why?
Polymorphism, Single Nucleotide
2
2020
552
0.130
 Why?
Incidence
2
2009
1082
0.130
 Why?
Disease Models, Animal
4
2016
1639
0.130
 Why?
Algorithms
1
2018
697
0.120
 Why?
Multivariate Analysis
6
2021
643
0.120
 Why?
Osteoclasts
3
2022
469
0.120
 Why?
Cystatin M
2
2024
21
0.120
 Why?
Altitude
1
2013
17
0.120
 Why?
Janus Kinase 2
1
2013
31
0.110
 Why?
STAT3 Transcription Factor
2
2010
87
0.110
 Why?
Cross-Sectional Studies
3
2023
1679
0.110
 Why?
Tomography, X-Ray Computed
2
2017
1213
0.110
 Why?
Protein-Tyrosine Kinases
3
2018
101
0.110
 Why?
Creatinine
2
2010
169
0.110
 Why?
Bone Density Conservation Agents
2
2010
83
0.110
 Why?
Viremia
1
2012
25
0.110
 Why?
Mice, Inbred C57BL
1
2018
1999
0.110
 Why?
Clone Cells
2
2023
89
0.110
 Why?
Models, Biological
1
2016
823
0.110
 Why?
Cytomegalovirus Infections
1
2012
46
0.110
 Why?
Clinical Trials, Phase III as Topic
1
2012
48
0.100
 Why?
Clinical Trials, Phase II as Topic
1
2012
51
0.100
 Why?
Models, Genetic
2
2016
209
0.100
 Why?
Viper Venoms
1
2011
7
0.100
 Why?
Case-Control Studies
3
2011
1228
0.100
 Why?
Chromosomes, Human, Pair 11
2
2020
54
0.100
 Why?
Epidemiologic Methods
2
2008
49
0.100
 Why?
Drug Evaluation, Preclinical
1
2012
158
0.100
 Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.100
 Why?
Arsenicals
1
2010
14
0.100
 Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
21
0.100
 Why?
Oxides
1
2010
19
0.100
 Why?
NF-kappa B
2
2018
335
0.100
 Why?
Mutation Rate
2
2021
40
0.100
 Why?
Granulocyte Colony-Stimulating Factor
2
2008
69
0.100
 Why?
Cytogenetic Analysis
5
2014
90
0.100
 Why?
Hypercalcemia
1
2010
36
0.100
 Why?
Transplantation, Homologous
4
2003
155
0.100
 Why?
Antineoplastic Agents, Hormonal
2
2007
49
0.090
 Why?
Janus Kinase 1
1
2010
20
0.090
 Why?
MAP Kinase Kinase 1
1
2010
26
0.090
 Why?
Cyclin-Dependent Kinases
1
2010
35
0.090
 Why?
Administration, Oral
2
2009
459
0.090
 Why?
Proteinuria
1
2010
52
0.090
 Why?
Anemia
1
2010
84
0.090
 Why?
Alleles
2
2021
277
0.090
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
101
0.090
 Why?
Genomics
2
2023
310
0.090
 Why?
Lorazepam
1
2009
13
0.090
 Why?
Diphosphonates
1
2010
96
0.090
 Why?
Hyperhomocysteinemia
1
2009
30
0.090
 Why?
Oxycodone
1
2009
24
0.090
 Why?
Receptors, Retinoic Acid
1
2009
27
0.090
 Why?
Anesthesia, Local
1
2009
19
0.090
 Why?
Prednisone
1
2009
111
0.090
 Why?
Tretinoin
1
2009
56
0.080
 Why?
Dose-Response Relationship, Drug
3
2008
1476
0.080
 Why?
Vasculitis
1
2008
30
0.080
 Why?
Hemostatic Techniques
1
2009
32
0.080
 Why?
Syndecan-1
3
2021
82
0.080
 Why?
Plasma Exchange
1
2009
33
0.080
 Why?
Histones
2
2021
335
0.080
 Why?
Vincristine
3
2003
98
0.080
 Why?
DNA Copy Number Variations
2
2021
114
0.080
 Why?
Cytogenetics
1
2008
28
0.080
 Why?
Bone Development
1
2009
69
0.080
 Why?
Cyclophosphamide
3
2003
172
0.080
 Why?
Bone Marrow Transplantation
3
2022
149
0.080
 Why?
Drug Therapy, Combination
1
2009
426
0.080
 Why?
Transcription Factors
2
2023
622
0.080
 Why?
Pain Measurement
1
2009
246
0.080
 Why?
Carrier Proteins
1
2010
359
0.080
 Why?
Platelet Aggregation
1
2008
82
0.080
 Why?
Biopsy
3
2018
692
0.080
 Why?
Radiopharmaceuticals
2
2021
238
0.080
 Why?
Thrombocytopenia
1
2009
99
0.080
 Why?
Staphylococcal Infections
2
2019
300
0.080
 Why?
Double-Blind Method
1
2009
742
0.080
 Why?
Brain Diseases, Metabolic
1
2007
7
0.080
 Why?
Phlebography
1
2007
70
0.080
 Why?
Hyperammonemia
1
2007
18
0.080
 Why?
Myeloma Proteins
1
2007
26
0.080
 Why?
Antimetabolites
1
2006
12
0.070
 Why?
Cell Communication
2
2023
72
0.070
 Why?
Chi-Square Distribution
1
2007
318
0.070
 Why?
Partial Thromboplastin Time
1
2006
12
0.070
 Why?
Transcriptome
2
2020
346
0.070
 Why?
Osteoprotegerin
1
2006
57
0.070
 Why?
Magnetic Resonance Imaging
4
2007
1604
0.070
 Why?
Heterozygote
1
2006
96
0.070
 Why?
Gastrointestinal Neoplasms
1
2006
46
0.070
 Why?
Antibiotics, Antineoplastic
1
2006
85
0.070
 Why?
Acetaminophen
1
2009
349
0.070
 Why?
Models, Statistical
1
2007
259
0.070
 Why?
Femur Head Necrosis
1
2005
17
0.070
 Why?
Pilot Projects
1
2008
808
0.070
 Why?
Neovascularization, Physiologic
1
2005
72
0.070
 Why?
Age Factors
3
2005
1195
0.070
 Why?
Syndrome
2
2019
252
0.060
 Why?
Gene Deletion
2
2003
293
0.060
 Why?
Apoptosis
1
2010
1300
0.060
 Why?
Ferritins
1
2024
31
0.060
 Why?
Glucuronidase
1
2003
48
0.060
 Why?
Myeloid Progenitor Cells
1
2023
19
0.060
 Why?
X-Ray Microtomography
1
2024
82
0.060
 Why?
Receptors, G-Protein-Coupled
1
2024
55
0.060
 Why?
DNA Methylation
2
2020
574
0.060
 Why?
DNA, Neoplasm
2
2020
171
0.060
 Why?
Discitis
1
2003
8
0.060
 Why?
Immunosuppressive Agents
1
2005
248
0.060
 Why?
Antibodies
1
2024
178
0.060
 Why?
Myeloproliferative Disorders
1
2003
28
0.060
 Why?
TNF Receptor-Associated Factor 3
1
2022
14
0.060
 Why?
Antigens, CD34
1
2003
80
0.060
 Why?
Oligonucleotide Array Sequence Analysis
4
2006
474
0.060
 Why?
Platelet Count
3
2008
77
0.050
 Why?
Tumor Cells, Cultured
3
2010
477
0.050
 Why?
Patients
1
2022
53
0.050
 Why?
Geography
1
2022
81
0.050
 Why?
Leukemia, Myeloid
1
2002
54
0.050
 Why?
Myeloid Differentiation Factor 88
1
2022
40
0.050
 Why?
Receptors, Antigen, T-Cell
1
2022
50
0.050
 Why?
Drug Interactions
1
2002
206
0.050
 Why?
Rats
1
2009
3415
0.050
 Why?
United States Food and Drug Administration
1
2022
97
0.050
 Why?
Chromosome Disorders
1
2002
39
0.050
 Why?
Oncogenes
1
2021
63
0.050
 Why?
Central Nervous System Neoplasms
1
2002
57
0.050
 Why?
Neoplasms, Second Primary
1
2002
77
0.050
 Why?
Hypothyroidism
1
2002
53
0.050
 Why?
Patient Selection
1
2023
286
0.050
 Why?
Phylogeny
1
2022
269
0.050
 Why?
RANK Ligand
1
2022
183
0.050
 Why?
Enzyme Inhibitors
1
2004
446
0.050
 Why?
Transcriptional Activation
1
2021
134
0.050
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
106
0.050
 Why?
Chromatin
1
2021
156
0.050
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.050
 Why?
Cyclin D2
1
2020
20
0.050
 Why?
Aneuploidy
1
2020
23
0.050
 Why?
Cohort Studies
2
2020
1543
0.050
 Why?
Proto-Oncogene Proteins c-maf
1
2020
20
0.050
 Why?
Chromosomes, Human, Pair 4
1
2020
30
0.050
 Why?
Pyrimidines
1
2022
196
0.050
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
105
0.050
 Why?
Gene Expression Regulation, Leukemic
1
2020
36
0.050
 Why?
Histone Code
1
2020
32
0.050
 Why?
Cyclin D1
1
2020
60
0.050
 Why?
Antibodies, Monoclonal, Humanized
1
2022
240
0.050
 Why?
ras Proteins
1
2020
70
0.050
 Why?
Chromosomes, Human, Pair 14
1
2020
76
0.050
 Why?
Protein Kinase Inhibitors
1
2022
216
0.050
 Why?
Endothelium, Vascular
1
2002
288
0.050
 Why?
Genome, Human
1
2021
131
0.050
 Why?
Longitudinal Studies
2
2016
746
0.050
 Why?
Transcriptional Elongation Factors
1
2020
28
0.050
 Why?
Genetic Loci
1
2020
58
0.040
 Why?
Postoperative Complications
1
2007
1033
0.040
 Why?
Health Status Disparities
1
2022
219
0.040
 Why?
DNA Mutational Analysis
1
2020
217
0.040
 Why?
RNA, Messenger
3
2010
1202
0.040
 Why?
Genetic Variation
1
2020
253
0.040
 Why?
Neoplastic Stem Cells
2
2015
103
0.040
 Why?
High-Throughput Nucleotide Sequencing
1
2020
206
0.040
 Why?
Pseudomonas Infections
1
2019
54
0.040
 Why?
Gram-Positive Bacterial Infections
1
2019
36
0.040
 Why?
Proline
1
2018
31
0.040
 Why?
Computational Biology
1
2020
231
0.040
 Why?
Bone Marrow Cells
2
2014
233
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.040
 Why?
Oncogene Proteins, Fusion
1
2018
60
0.040
 Why?
DNA-Binding Proteins
1
2021
462
0.040
 Why?
Proteolysis
1
2018
102
0.040
 Why?
Fluorescent Dyes
1
2018
116
0.040
 Why?
Extracellular Matrix
1
2018
111
0.040
 Why?
Recombinant Proteins
2
2010
569
0.040
 Why?
Promoter Regions, Genetic
1
2020
520
0.040
 Why?
Kidney Function Tests
1
2017
59
0.040
 Why?
False Positive Reactions
1
2017
68
0.040
 Why?
Cell Movement
1
2018
271
0.040
 Why?
Glomerular Filtration Rate
1
2017
138
0.040
 Why?
Genes, ras
1
2016
48
0.040
 Why?
Mice, SCID
2
2009
196
0.040
 Why?
Genes, p53
1
2016
60
0.040
 Why?
Amino Acid Sequence
1
2018
767
0.040
 Why?
Cell Survival
2
2010
657
0.040
 Why?
Genetic Predisposition to Disease
1
2020
570
0.040
 Why?
Glycolysis
1
2016
73
0.040
 Why?
Chromosome Mapping
2
2006
175
0.030
 Why?
Image Interpretation, Computer-Assisted
1
2016
119
0.030
 Why?
Phosphatidylinositol 3-Kinases
1
2016
153
0.030
 Why?
Syndecans
2
2006
43
0.030
 Why?
Proteoglycans
2
2006
96
0.030
 Why?
Drug Monitoring
1
2015
85
0.030
 Why?
Interspersed Repetitive Sequences
1
2014
10
0.030
 Why?
Cells, Cultured
1
2018
1737
0.030
 Why?
Karyotype
1
2014
19
0.030
 Why?
Myocardium
1
2017
441
0.030
 Why?
Proportional Hazards Models
2
2006
431
0.030
 Why?
Membrane Glycoproteins
2
2006
269
0.030
 Why?
Transplantation Chimera
2
2003
15
0.030
 Why?
Cytomegalovirus
1
2012
30
0.030
 Why?
Neoplasm Staging
2
2007
806
0.030
 Why?
RNA Interference
1
2013
195
0.030
 Why?
Virus Activation
1
2012
30
0.030
 Why?
Viral Load
1
2012
85
0.030
 Why?
Graft vs Host Disease
2
2003
83
0.030
 Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
 Why?
Cell Growth Processes
1
2010
24
0.020
 Why?
United States
1
2022
5200
0.020
 Why?
Antiviral Agents
1
2012
188
0.020
 Why?
CDC2-CDC28 Kinases
1
2010
15
0.020
 Why?
Femur
1
2010
144
0.020
 Why?
Long-Term Care
1
2010
58
0.020
 Why?
Peripheral Nervous System Diseases
1
2010
63
0.020
 Why?
RNA, Small Interfering
1
2010
252
0.020
 Why?
Bone Diseases, Metabolic
1
2010
82
0.020
 Why?
Down-Regulation
1
2010
388
0.020
 Why?
Abnormalities, Multiple
1
2010
159
0.020
 Why?
Protein Isoforms
1
2009
124
0.020
 Why?
Cell Transformation, Neoplastic
1
2010
200
0.020
 Why?
Ploidies
1
2008
13
0.020
 Why?
Ligands
1
2009
230
0.020
 Why?
Serum Albumin
1
2008
62
0.020
 Why?
Hemoglobins
1
2008
126
0.020
 Why?
Polyethylene Glycols
1
2008
106
0.020
 Why?
Rabbits
1
2009
425
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
673
0.020
 Why?
Age Distribution
1
2007
198
0.020
 Why?
Ammonia
1
2007
73
0.020
 Why?
C-Reactive Protein
1
2008
159
0.020
 Why?
Multigene Family
1
2006
54
0.020
 Why?
Diagnosis, Differential
1
2010
1136
0.020
 Why?
Blood Proteins
1
2007
100
0.020
 Why?
Mass Screening
1
2010
370
0.020
 Why?
Cyclin D
1
2006
20
0.020
 Why?
RNA, Neoplasm
1
2006
54
0.020
 Why?
Bone Density
1
2009
416
0.020
 Why?
Cyclins
1
2006
54
0.020
 Why?
Evidence-Based Medicine
1
2007
281
0.020
 Why?
Brain
2
2007
1387
0.020
 Why?
Leukemia, Myeloid, Acute
1
2007
191
0.020
 Why?
Coculture Techniques
1
2006
160
0.020
 Why?
Radiography
1
2007
524
0.020
 Why?
Data Interpretation, Statistical
1
2006
177
0.020
 Why?
Neoplasms, Experimental
1
2006
115
0.020
 Why?
Interferon-alpha
1
2005
50
0.020
 Why?
Survivors
1
2006
137
0.020
 Why?
Databases, Factual
1
2007
684
0.020
 Why?
Mice, Transgenic
1
2006
656
0.010
 Why?
Monosomy
1
2003
5
0.010
 Why?
Trisomy
1
2003
34
0.010
 Why?
Endothelial Growth Factors
1
2003
8
0.010
 Why?
History, 21st Century
1
2003
62
0.010
 Why?
Vascular Endothelial Growth Factors
1
2003
16
0.010
 Why?
Odds Ratio
1
2005
604
0.010
 Why?
Lymphokines
1
2003
20
0.010
 Why?
Stem Cell Factor
1
2003
7
0.010
 Why?
Fusion Proteins, bcr-abl
1
2003
23
0.010
 Why?
Lymphocyte Transfusion
1
2003
12
0.010
 Why?
Interphase
1
2003
14
0.010
 Why?
History, 20th Century
1
2003
114
0.010
 Why?
Diploidy
1
2003
30
0.010
 Why?
Confidence Intervals
1
2003
167
0.010
 Why?
Leukocyte Count
1
2003
77
0.010
 Why?
Probability
1
2003
176
0.010
 Why?
Back Pain
1
2003
44
0.010
 Why?
Interferons
1
2002
44
0.010
 Why?
Infusions, Intravenous
1
2003
231
0.010
 Why?
Cell Count
1
2003
181
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2003
122
0.010
 Why?
Sex Factors
1
2005
765
0.010
 Why?
Drug Administration Schedule
1
2003
401
0.010
 Why?
Thyroid Function Tests
1
2002
25
0.010
 Why?
Thyrotropin
1
2002
46
0.010
 Why?
Tissue Donors
1
2003
110
0.010
 Why?
Prevalence
1
2005
1022
0.010
 Why?
Neutrophils
1
2003
154
0.010
 Why?
Fatal Outcome
1
2002
225
0.010
 Why?
Reoperation
1
2003
454
0.010
 Why?
Cell Division
1
2002
330
0.010
 Why?
Acute Disease
1
2002
403
0.010
 Why?
Up-Regulation
1
2002
508
0.010
 Why?
Anti-Bacterial Agents
1
2003
820
0.010
 Why?
Zangari's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (493) concept(s)
_
Co-Authors Expand Description
See all (54) people
_
Similar People Expand Description
See all (28) people
_
Same Department Expand Description
Search Department